| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥174.4B | ¥180.7B | -3.5% |
| Operating Income | ¥-0.6B | ¥5.3B | -7.3% |
| Ordinary Income | ¥-2.3B | ¥5.5B | -14.7% |
| Net Income | ¥-3.1B | ¥1.4B | -66.6% |
| ROE | -4.2% | 1.7% | - |
FY2025 results showed revenue of 174.4B yen (YoY -3.5%), operating income of -0.6B yen (turned to loss from prior year's 5.3B yen operating income), ordinary income of -2.3B yen (YoY -14.7%), and net income attributable to owners of -3.1B yen (YoY -66.6%). The company faced a challenging period with operating loss driven by SG&A expenses exceeding gross profit, despite maintaining gross margin of 37.1%. Extraordinary losses of 9.9B yen, primarily from impairment loss of 8.6B yen and restructuring costs of 1.3B yen, significantly impacted bottom-line performance. Operating cash flow remained positive at 6.0B yen (YoY +2.9%), indicating continued operational cash generation capability. Total assets decreased to 187.4B yen from 200.9B yen, while equity declined to 74.2B yen from 86.2B yen, reflecting the net loss impact on retained earnings.
Revenue declined 3.5% YoY to 174.4B yen, reflecting challenging market conditions in the electronic musical instruments segment. Cost of sales decreased to 109.7B yen, resulting in gross profit of 64.7B yen with gross margin of 37.1% (prior year 38.3%), representing a 1.2pt margin contraction. The decline in gross margin suggests pricing pressure or unfavorable product mix shifts. SG&A expenses increased to 65.3B yen from 64.0B yen (YoY +2.1%), resulting in SG&A ratio of 37.4% versus 35.4% prior year, demonstrating operating leverage deterioration as fixed costs remained elevated despite revenue decline. This cost structure resulted in operating loss of 0.6B yen versus prior operating income of 5.3B yen.
Non-operating expenses totaled 2.6B yen, primarily comprising interest expenses of 1.3B yen and foreign exchange losses of 1.3B yen, offsetting non-operating income of 0.9B yen (including dividend income of 0.5B yen). This resulted in ordinary income of -2.3B yen. The gap between operating and ordinary income of 1.7B yen reflects increased financial burdens from foreign exchange volatility and interest costs on elevated debt levels.
Extraordinary losses of 9.9B yen significantly impacted net income, consisting of impairment loss of 8.6B yen and restructuring costs of 1.3B yen as non-recurring factors. The impairment suggests asset value write-downs, likely related to goodwill (decreased 11.0B yen YoY to 18.9B yen) and intangible assets (decreased 11.0B yen to 19.6B yen). After tax effects (net tax benefit of 3.7B yen due to losses), net income attributable to owners was -3.1B yen, compared to prior year's 0.1B yen, representing a 66.6% deterioration. The result represents a revenue down/profit down pattern, with structural profitability challenges compounded by significant one-time charges.
[Profitability] Operating margin deteriorated to -0.3% from prior year 2.9%, reflecting 3.2pt contraction driven by SG&A expense deleverage. ROE turned negative to -4.2% from prior positive 0.6%, impacted by net loss generation. Gross profit margin of 37.1% declined 1.2pt from 38.3%, indicating modest pricing or mix pressure. [Cash Quality] Cash and deposits stood at 30.9B yen, providing 0.64x coverage of short-term debt (short-term loans of 48.5B yen plus current portion of long-term loans of 4.7B yen totaling 53.2B yen), warranting monitoring of near-term liquidity. Operating cash flow of 6.0B yen represented -1.9x net income coverage (negative ratio due to net loss), with operating CF subtotal before working capital of 10.6B yen indicating underlying operational cash generation capability remains intact despite reported losses. [Investment Efficiency] Total asset turnover improved slightly to 0.93x from 0.90x, though absolute asset efficiency remains moderate. Inventory of 77.9B yen represents 44.7% of total assets and increased 6.0% YoY despite revenue decline, suggesting inventory turnover deterioration and potential obsolescence risk. [Financial Health] Equity ratio declined to 39.6% from 42.9%, reflecting equity erosion from net losses. Current ratio of 180.6% indicates adequate liquidity buffer, though quick ratio of 84.6% shows more constrained immediate liquidity when excluding inventory. Debt-to-equity ratio increased to 0.93x from 0.82x, with total interest-bearing debt of 68.9B yen representing elevated leverage given negative operating performance.
Operating cash flow of 6.0B yen increased 2.9% YoY, demonstrating continued operational cash generation despite net loss of -3.1B yen, resulting in operating CF to net income ratio of -1.9x (negative due to loss). Operating CF subtotal before working capital changes of 10.6B yen included non-cash adjustments of depreciation and amortization 3.7B yen, impairment loss 8.6B yen, and amortization of goodwill 4.8B yen. Working capital movements were favorable overall, with decrease in trade receivables contributing 4.0B yen inflow, partially offset by increase in trade payables consuming 1.8B yen. Inventory decrease contributed 0.9B yen, though ending inventory absolute level of 77.9B yen remains elevated relative to revenue run-rate. Income taxes paid of 3.5B yen and interest paid of 1.5B yen represented significant cash outflows. Investing cash flow of -6.9B yen primarily consisted of capital expenditures of 4.0B yen, representing 1.08x depreciation coverage and indicating maintenance-plus investment levels. Financing cash flow of -1.1B yen reflected net short-term loan increase of 6.6B yen offset by long-term loan repayments of 5.1B yen, dividend payments of 1.4B yen, and share repurchases of 0.4B yen. Free cash flow of -0.9B yen (operating CF minus investing CF) indicates limited capacity to fund shareholder returns from internally generated cash, with dividend payments exceeding FCF by 0.5B yen, suggesting reliance on debt refinancing to maintain capital allocation.
Ordinary income of -2.3B yen versus operating income of -0.6B yen shows non-operating net loss of approximately 1.7B yen, comprising primarily interest expenses of 1.3B yen and foreign exchange losses of 1.3B yen, partially offset by dividend income of 0.5B yen. Non-operating expenses represent 1.5% of revenue and increased from prior year, reflecting higher financial burdens. Extraordinary losses of 9.9B yen consist entirely of non-recurring items, including impairment loss of 8.6B yen and restructuring costs of 1.3B yen, representing 5.7% of revenue and materially distorting reported earnings. Adjusting for these extraordinary items, underlying pre-tax loss would be approximately -2.3B yen versus reported -12.2B yen, indicating that while core operations remain challenged, the magnitude of reported loss is heavily influenced by one-time charges. Operating cash flow of 6.0B yen significantly exceeds net income, driven by non-cash charges (impairment, goodwill amortization totaling 13.4B yen), indicating that cash earnings quality is healthier than reported accounting earnings, though underlying operating profitability remains negative. The divergence between comprehensive income of -10.5B yen and net income of -3.1B yen reflects primarily foreign currency translation adjustment gain of 5.3B yen in other comprehensive income, suggesting balance sheet translation effects partially offset P&L performance deterioration.
Full-year guidance projects revenue of 175.0B yen (YoY +0.4%), operating income of 6.5B yen, ordinary income of 5.5B yen, and net income attributable to owners of 2.0B yen. Current period represents full-year results, achieving 99.6% of revenue forecast, operating loss versus forecast profit indicating underperformance, ordinary loss versus forecast profit of 5.5B yen representing significant shortfall, and net loss versus forecast profit of 2.0B yen. The substantial variance between actual and forecast primarily stems from extraordinary losses of 9.9B yen not anticipated in guidance. Adjusting for extraordinary items, underlying ordinary income would approximate forecast levels, suggesting core operational performance tracked closer to expectations despite operating loss. The company maintains modest revenue growth expectation of 0.4% for next fiscal year, indicating cautious outlook on demand recovery. Operating income guidance of 6.5B yen implies operating margin recovery to 3.7%, requiring successful execution of cost structure improvements and elimination of current year's one-time charges. Given prior year operating margin of 2.9% and current year's -0.3%, the 3.7% target represents ambitious improvement requiring both revenue stability and SG&A rationalization. Forecast notes indicate that projections are based on currently available information and assumptions deemed reasonable, with actual results potentially varying significantly due to various factors, and reference earnings outlook discussion on page 5 of supplementary materials for detailed assumptions. Investor presentation scheduled for February 18, 2026, with materials and video to be posted on company website, providing opportunity to assess management's strategic initiatives and forecast assumptions.
Annual dividend of 32.00 yen per share is planned, consisting of year-end dividend of 31.00 yen (Q2 interim dividend was 0.00 yen). Prior year paid year-end dividend only, though specific amount disclosure differs between periods. Payout ratio of 3.3% as reported appears inconsistent with net loss position, likely calculated on adjusted or normalized earnings basis, though calculation methodology is unclear. Dividend payment of 1.3B yen against net income of -3.1B yen and free cash flow of -0.9B yen indicates dividend is not covered by either earnings or free cash flow, representing total return ratio exceeding 100% when calculated against current period metrics. Share repurchases of 0.4B yen were executed during the period, bringing total shareholder returns (dividends plus buybacks) to approximately 1.7B yen. This capital allocation totaling 1.7B yen against negative FCF of -0.9B yen and operating CF of 6.0B yen suggests company prioritized maintaining shareholder returns despite challenging earnings, likely funding distributions through debt refinancing as evidenced by net short-term borrowing increase. Sustainability of current dividend policy warrants monitoring given earnings volatility and cash flow constraints, though company's commitment to maintain returns may reflect confidence in earnings recovery or strategic priority to support shareholder base during restructuring period.
Inventory obsolescence risk with inventory of 77.9B yen representing 44.7% of total assets and increasing despite revenue decline, suggesting potential excess stock vulnerable to write-downs if demand recovery does not materialize or product cycles shift. Calculated days inventory outstanding significantly exceeds typical industry ranges for manufacturing, indicating extended holding periods and capital inefficiency. Liquidity and refinancing risk from short-term debt concentration of 48.5B yen short-term loans plus 4.7B yen current portion of long-term debt totaling 53.2B yen, representing 70.4% of total interest-bearing debt, covered only 0.64x by cash position of 30.9B yen. This maturity mismatch creates vulnerability to credit market conditions and interest rate volatility, particularly concerning given negative operating profitability reducing debt service capacity. Interest coverage calculated as EBIT divided by interest expense shows -0.45x, indicating inability to cover interest from operating earnings, with Debt/EBITDA ratio of 22.06x representing severely elevated leverage given current profitability levels. Structural profitability pressure with SG&A expenses of 65.3B yen exceeding gross profit of 64.7B yen, resulting in negative operating leverage where fixed cost base cannot be supported by current revenue and margin levels. Without successful cost restructuring or revenue recovery, sustained operating losses would further erode equity base (already declined from 86.2B yen to 74.2B yen) and compound refinancing challenges, potentially requiring capital injection or asset monetization to restore financial stability.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of -0.3% (industry comparison not quantified due to limited benchmark data availability). The company's gross margin of 37.1% demonstrates product-level profitability capability typical of specialized electronic equipment manufacturers, though SG&A burden of 37.4% of revenue significantly exceeds efficiency benchmarks for the sector. ROE of -4.2% reflects current period loss impact, whereas normalized ROE based on historical performance and industry standards would typically range 8-15% for established electronic musical instrument manufacturers.
Financial Health: Equity ratio of 39.6% indicates moderate capitalization, though declining trend from 42.9% warrants monitoring. Industry standards for durable goods manufacturers typically maintain equity ratios above 40-50% for financial flexibility. Current ratio of 180.6% exceeds typical industry adequacy thresholds of 150%, though quick ratio of 84.6% is constrained by elevated inventory levels relative to peers who typically maintain 100-120% quick ratios.
Efficiency: Asset turnover of 0.93x aligns with capital-intensive manufacturing sector norms of 0.8-1.2x, though inventory representing 44.7% of assets significantly exceeds industry typical range of 25-35%, indicating room for working capital optimization. The company's inventory days outstanding materially exceeds sector medians, suggesting competitive disadvantage in supply chain and demand forecasting efficiency.
Note: Industry benchmark data represents general characteristics of electronic equipment manufacturing sector due to limited directly comparable public company data for specialized musical instrument electronics. Company demonstrates product differentiation capability (gross margin preservation) but faces execution challenges in operational efficiency and cost management relative to sector operating standards.
Significant restructuring and asset impairment charges of 9.9B yen (8.6B yen impairment plus 1.3B yen restructuring costs) indicate management undertaking portfolio rationalization and cost base reset, with goodwill reduction of 11.0B yen suggesting acquisition-related asset value reassessment. These one-time charges, while depressing current earnings, potentially position the company for improved future profitability if successful restructuring delivers anticipated cost savings and operational improvements. Structural profitability challenge evident from SG&A expenses exceeding gross profit, requiring either revenue growth acceleration, margin expansion through pricing or mix improvement, or sustained cost reduction to restore positive operating leverage. Management's full-year guidance of 6.5B yen operating income implies 3.7% operating margin, representing 4.0pt improvement from current -0.3%, indicating meaningful operational transformation required. Working capital inefficiency with inventory of 77.9B yen (44.7% of assets) increasing despite revenue decline presents both risk and opportunity, as inventory normalization could release significant cash (potential 10-15B yen if reduced to industry-typical 30-35% of assets) to strengthen liquidity and reduce debt, though realization depends on demand recovery and successful sell-through without excessive discounting. Near-term financial flexibility constrained by short-term debt concentration and negative free cash flow, with dividend payments exceeding FCF suggesting reliance on debt refinancing, making execution of forecast turnaround critical to avoid covenant or liquidity pressures that could require additional capital raising or further restructuring.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.